Shubash Adhikari
Cardiovascular Disease · Burlington, VTNPI 1861809741
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.6%), grants and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 33.4% of the total.
Across 353 payments — averaging $166.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$20K
- Medtronic$19K
- Boston Scientific$9K
- Biosense Webster, Inc.$5K
- Medical Device Business Services, Inc.$3K
- Biotronik Inc.$907
- plus $2K from 12 others
What the payments were for
- Grants$14,00024%
- Travel & lodging$29,05550%
- Food & beverage$13,20423%
- Education$2,3754%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 83 | $19,608 |
| Medtronic | 118 | $18,960 |
| Boston Scientific | 37 | $8,908 |
| Biosense Webster, Inc. | 34 | $4,599 |
| Medical Device Business Services, Inc. | 25 | $3,389 |
| Biotronik Inc. | 2 | $907 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 27 | $733 |
| Heartflow, Inc. | 4 | $383 |
| AstraZeneca | 10 | $350 |
| Johnson & Johnson | 2 | $283 |
| E.r. Squibb & Sons, L.L.C. | 2 | $146 |
| Impulse Dynamics (USA) Inc. | 1 | $103 |
| Amgen | 3 | $92 |
| Abiomed | 1 | $52 |
| Kestra Medical Technology Services, Inc. | 1 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| ZOLL Circulation Inc | 1 | $22 |
| Novartis | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$6,964
- ENSITE$3,677
- ASSURITY$2,250
- TACTICATH$2,250
- ENSITE PRECISION$2,243
- VersaCross Access Solution$1,714
- GALLANT$1,394
- WATCHMAN Access System$1,033
- CARDIOMEMS$778
- Micra$630
- NA$404
- SelectSecure$316
- FFRct$307
- XARELTO$283
- EnSite Precision Cardiac Mapping System$211
- OPTIMIZER$206
- ADVISA DR MRI SURESCAN$185
- Orsiro Mission$141
- CAMZYOS$125
- CLARIA MRI QUAD CRT-D SURESCAN$108
How this compares
$58,634 in reported general payments places this provider in the 85th percentile of 27 cardiovascular disease providers in Vermont.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $15,659 |
| Metoprolol Succinate | 36 | $426 |
| Rosuvastatin Calcium | 23 | $386 |
| ClopidogrelClopidogrel Bisulfate | 24 | $276 |
| Atorvastatin Calcium | 35 | $187 |
| Spironolactone | 16 | $136 |
| Pantoprazole Sodium | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Burlington
- Harold DauermanBurlington$248K
- Daniel LustgartenBurlington$171K
- Adipong BrickshawanaBurlington$37K
- Thomas GillilandBurlington$35K
- Benjamin IrvineBurlington$11K
- David SchneiderBurlington$7K
- Ahmed HarhashBurlington$6K
- Sharan SharmaBurlington$4K
- Trace BarrettBurlington$4K
- Sherrie KhadangaBurlington$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.